Latest GlaxoSmithKline Stories
Proceeds to Fund Phase 2b Study of FV-100 Fast-Acting Oral Antiviral EDISON, N.J., Oct. 15, 2014 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.
RALEIGH, N.C., Oct. 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that J.
CARLSBAD, Calif., Oct. 9, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
NEW YORK, Oct.
Emerging Anticytokines, Are Expected to Drive the Market Growth and Open a New Era of Personalized Medicine in Asthma, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Half of Surveyed Nephrologists Were Aware that the FDA had Approved American Regent's IV Iron Injectafer, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
Companies Include Silarus Therapeutics Developing Treatments for Anemia and Iron Overload Disorders; and Thyritope Biosciences Developing Treatments for Graves' Orbitopathy SAN DIEGO,
LifeScienceIndustryResearch.com adds “Flovent (Asthma) – Forecast and Market Analysis to 2023” to its store.
- totally perplexed and mixed up.